Pumin Zhang

机构：Guangxi Medical University, Zhejiang Cancer Hospital, Theranostics (New Zealand), Zhejiang Institute of Mechanical and Electrical Engineering, First Affiliated Hospital Zhejiang University, Zhejiang University · ORCID：0000-0003-4063-3008

发表论文 67 篇 · 总被引 6009 次 · h-index 28

代表论文

• USP25 regulates KEAP1-NRF2 anti-oxidation axis and its inactivation protects acetaminophen-induced liver injury in male mice (2023 · Nature Communications · 被引 67)
• Identification of a class of potent USP25/28 inhibitors with broad-spectrum anti-cancer activity (2022 · Signal Transduction and Targeted Therapy · 被引 25)
• Ubiquitin‐specific protease 28 deubiquitinates TCF7L2 to govern the action of the Wnt signaling pathway in hepatic carcinoma (2022 · Cancer Science · 被引 24)
• Advances in preclinical and clinical studies of oncolytic virus combination therapy (2025 · Frontiers in Oncology · 被引 20)
• Functional Phosphoproteomics in Cancer Chemoresistance Using CRISPR‐Mediated Base Editors (2022 · Advanced Science · 被引 18)
• Resistance and recurrence of malignancies after CAR-T cell therapy (2021 · Experimental Cell Research · 被引 16)